Marjolein A. Heuvelmans

Papers

Total Citations

H-Index

About

Dr. Marjolein A. Heuvelmans is a leading thoracic oncologist whose research focuses on the early detection, diagnosis, and management of lung cancer, with a particular emphasis on low-dose CT screening and nodule management. Her major contributions include advancing evidence-based strategies for optimizing lung cancer screening protocols and improving the characterization of pulmonary nodules to reduce unnecessary interventions. Her work has been instrumental in shaping international guidelines for nodule follow-up and risk stratification. With over 2,000 citations across her publications, Dr. Heuvelmans has had a profound impact on the field, particularly through her involvement in the Dutch-Belgian Randomized Lung Cancer Screening Trial (NELSON) and her leadership in the European Respiratory Society’s Thoracic Oncology Assembly. Her recent highlight from the ERS Congress 2024 underscores her continued influence in translating cutting-edge research into clinical practice. Dr. Heuvelmans’ dedication to improving outcomes for patients with thoracic malignancies makes her a pivotal figure in the fight against lung cancer.